Aktie GENEREX BIOTECHNOLOGY CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Generex Biotechnology Corporation OTC Bulletin Board

Aktien

US3714851033

Schlusskurs OTC Bulletin Board
Andere Börsenplätze
- USD - Intraday Chart für Generex Biotechnology Corporation
2022 Unfreiwillige Petition für Generex Biotechnology Corporation genehmigt CI
2022 Unfreiwillige Petition gegen Generex Biotechnology Corporation eingereicht CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Motion for Asset Sale Approved for Generex Biotechnology Corporation
Motion for Asset Sale Filed by Generex Biotechnology Corporation
Motion for Asset Sale Approved for Generex Biotechnology Corporation
Amended Bidding Procedure Approved for Generex Biotechnology Corporation
Involuntary Petition Approved for Generex Biotechnology Corporation
Involuntary Petition Filed Against Generex Biotechnology Corporation
Generex Biotechnology Corporation : Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical, has gained approval for the use of Excellagen® Wound Conforming Matrix from The Malaysian Ministry of Health, its country’s equivalent to the U.S. FDA
Generex Biotechnology : Material Event (Form 8-K)
GENEREX BIOTECHNOLOGY CORP : Other Events (form 8-K)
Generex Biotechnology Corporation Enters into Quality Agreement with PPD Development, L.P
Generex Biotechnology : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Unregistered Sales of Equity Securities (Form 8-K)
GENEREX BIOTECHNOLOGY CORP : Unregistered Sale of Equity Securities (form 8-K)
Generex Biotechnology Corporation announced that it has received $1 million in funding
NuGenerex Immuno-Oncology Secures $535 Million Valuation from World-Class Independent Valuation & Appraisal Firm
GENEREX BIOTECHNOLOGY : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Generex Biotechnology Corporation Reports Earnings Results for the Third Quarter Ended April 30, 2021
GENEREX BIOTECHNOLOGY CORP : Other Events (form 8-K)
Generex Biotechnology : Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring (RPM) Services
Generex Biotechnology Corporation Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring Services
Generex Posts Recording of May 6 Shareholder Conference Call Highlighting its Ii-Key COVID Complete Vaccine™ and its Go-Forward Plans for Revenue Producing Assets
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2DL9M Aktie
  4. Aktie
  5. Nachrichten Generex Biotechnology Corporation
  6. Andere Sprachen